Search Results - "Trawinska, M M"

Severe Peripheral Arterial Disease During Nilotinib Therapy by Le Coutre, Philipp, Rea, Delphine, Abruzzese, Elisabetta, Dombret, Hervé, Trawinska, Malgorzata M., Herndlhofer, Susanne, Dörken, Bernd, Valent, Peter

Get full text

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study by Palandri, F., Auteri, G., Abruzzese, E., Caocci, G., Bonifacio, M., Mendicino, F., Latagliata, R., Iurlo, A., Branzanti, F., Garibaldi, B., Trawinska, M. M., Cattaneo, D., Krampera, M., Mulas, O., Martino, E. A., Cavo, M., Vianelli, N., Impera, S., Efficace, F., Heidel, F., Breccia, M., Elli, E. M., Palumbo, G. A.

“…Ruxolitinib is beneficial in patients with myelofibrosis (MF) and polycythemia vera (PV). Information on ruxolitinib adherence is scant. The Ruxolitinib…”
Get full text

Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome by Palandri, Francesca, Breccia, Massimo, Mazzoni, Camilla, Auteri, Giuseppe, Elli, Elena Maria, Trawinska, Malgorzata M., Polverelli, Nicola, Tiribelli, Mario, Benevolo, Giulia, Iurlo, Alessandra, Tieghi, Alessia, Heidel, Florian H., Caocci, Giovanni, Beggiato, Eloise, Binotto, Gianni, Cavazzini, Francesco, Miglino, Maurizio, Bosi, Costanza, Crugnola, Monica, Bocchia, Monica, Martino, Bruno, Pugliese, Novella, Biondo, Mattia, Venturi, Marta, Scaffidi, Luigi, Isidori, Alessandro, Cattaneo, Daniele, Krampera, Mauro, Pane, Fabrizio, Cilloni, Daniela, Semenzato, Gianpietro, Lemoli, Roberto M., Cuneo, Antonio, Abruzzese, Elisabetta, Bartoletti, Daniela, Paglia, Simona, Vianelli, Nicola, Cavo, Michele, Bonifacio, Massimiliano, Palumbo, Giuseppe A.

“…Background Patients with cytopenic myelofibrosis (MF) have more limited therapeutic options and poorer prognoses compared with patients with the…”
Get full text

P1010: RUXOLITINIB IN MYELODEPLETIVE MYELOFIBROSIS: RESPONSE, TOXICITY, AND OUTCOME by Palandri, F., Bartoletti, D., Breccia, M., Auteri, G., Elli, E. M., Trawinska, M. M., Polverelli, N., Tiribelli, M., Benevolo, G., Iurlo, A., Tieghi, A., Heidel, F. H., Caocci, G., Beggiato, E., Binotto, G., Cavazzini, F., Miglino, M., Bosi, C., Crugnola, M., Bocchia, M., Martino, B., Pugliese, N., Romagnoli, A. D., Mazzoni, C., Scaffidi, L., Isidori, A., Cattaneo, D., Krampera, M., Pane, F., Cilloni, D., Semenzato, G., Lemoli, R. M., Cuneo, A., Abruzzese, E., Vianelli, N., Cavo, M., Bonifacio, M., Palumbo, G. A.

Get full text

P1011: PREDICTORS OF COVID‐19 DISEASE AND SURVIVAL TO COVID‐19 IN MPN PATIENTS TREATED WITH RUXOLITINIB by Palandri, F., Bartoletti, D., Elli, E. M., Auteri, G., Bonifacio, M., Benevolo, G., Heidel, F., Trawinska, M. M., Rossi, E., Bosi, C., Tieghi, A., Tiribelli, M., Iurlo, A., Polverelli, N., Caocci, G., Binotto, G., Cavazzini, F., Beggiato, E., Cilloni, D., Tatarelli, C., Mendicino, F., Miglino, M., Bocchia, M., Crugnola, M., Mazzoni, C., Romagnoli, A. D., Rindone, G., Ceglie, S., D'Addio, A., Santoni, E., Cattaneo, D., Lemoli, R. M., Krampera, M., Cuneo, A., Semenzato, G., Latagliata, R., Abruzzese, E., Vianelli, N., Cavo, M., Andriani, A., De Stefano, V., Palumbo, G., Breccia, M.

Get full text

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer: comment by Tendas, A., Scaramucci, L., Cupelli, L., Lentini, R., Trawinska, M. M., Giovannini, M., Perrotti, A., Fabritiis, P., Niscola, P.

Get full text

CD34+ Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate by Bocchia, M, Ippoliti, M, Gozzetti, A, Abruzzese, E, Calabrese, S, Amabile, M, Pirrotta, M T, Crupi, R, Tozzuoli, D, Trawinska, M M, Defina, M, Martinelli, G, Lauria, F

Get full text

Accidental falls in home care hematological patients by Tendas, A., Cupelli, L., Trawinska, M. M., Lentini, L., Giovannini, M., Scaramucci, L., Palombi, M., Brunetti, G. A., Cartoni, C., de Fabritiis, P., Niscola, P., Mandelli, F.

Get full text

Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura by Stasi, Roberto, Del Poeta, Giovanni, Stipa, Elisa, Evangelista, Maria Laura, Trawinska, Margherita M., Cooper, Nichola, Amadori, Sergio

“…Rituximab, an anti-CD20 monoclonal antibody, has been used to treat autoimmune disorders such as idiopathic thrombocytopenic purpura (ITP). However, its…”
Get full text

Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib by Palandri, Francesca, Elli, Elena M., Auteri, Giuseppe, Bonifacio, Massimiliano, Benevolo, Giulia, Heidel, Florian H., Paglia, Simona, Trawinska, Malgorzata M., Bosi, Costanza, Rossi, Elena, Tiribelli, Mario, Tieghi, Alessia, Iurlo, Alessandra, Polverelli, Nicola, Caocci, Giovanni, Binotto, Gianni, Cavazzini, Francesco, Beggiato, Eloise, Cilloni, Daniela, Tatarelli, Caterina, Mendicino, Francesco, Miglino, Maurizio, Bocchia, Monica, Crugnola, Monica, Mazzoni, Camilla, Romagnoli, Andrea D., Rindone, Giovanni, Ceglie, Sara, D’Addio, Alessandra, Santoni, Eleonora, Cattaneo, Daniele, Bartoletti, Daniela, Lemoli, Roberto M., Krampera, Mauro, Cuneo, Antonio, Semenzato, Gianpietro C., Latagliata, Roberto, Abruzzese, Elisabetta, Vianelli, Nicola, Cavo, Michele, Andriani, Alessandro, De Stefano, Valerio, Palumbo, Giuseppe A., Breccia, Massimo

Get full text

Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome by Palandri, Francesca, Tiribelli, Mario, Breccia, Massimo, Bartoletti, Daniela, Elli, Elena M., Benevolo, Giulia, Martino, Bruno, Cavazzini, Francesco, Tieghi, Alessia, Iurlo, Alessandra, Abruzzese, Elisabetta, Pugliese, Novella, Binotto, Gianni, Caocci, Giovanni, Auteri, Giuseppe, Cattaneo, Daniele, Trawinska, Malgorzata M., Stella, Rossella, Scaffidi, Luigi, Polverelli, Nicola, Micucci, Giorgia, Masselli, Elena, Crugnola, Monica, Bosi, Costanza, Heidel, Florian H., Latagliata, Roberto, Pane, Fabrizio, Cuneo, Antonio, Krampera, Mauro, Semenzato, Gianpietro, Lemoli, Roberto M., Cavo, Michele, Vianelli, Nicola, Bonifacio, Massimiliano, Palumbo, Giuseppe A.

“…BACKGROUND After ruxolitinib discontinuation, the outcome of patients with myelofibrosis (MF) is poor with scarce therapeutic possibilities. METHODS The…”
Get full text

Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy by Palandri, Francesca, Palumbo, Giuseppe A., Benevolo, Giulia, Iurlo, Alessandra, Elli, Elena M., Abruzzese, Elisabetta, Polverelli, Nicola, Tiribelli, Mario, Auteri, Giuseppe, Tieghi, Alessia, Caocci, Giovanni, Binotto, Gianni, Cavazzini, Francesco, Branzanti, Filippo, Beggiato, Eloise, Miglino, Maurizio, Bosi, Costanza, Crugnola, Monica, Bocchia, Monica, Martino, Bruno, Pugliese, Novella, Scaffidi, Luigi, Venturi, Marta, Duminuco, Andrea, Isidori, Alessandro, Cattaneo, Daniele, Krampera, Mauro, Pane, Fabrizio, Cilloni, Daniela, Semenzato, Gianpietro, Lemoli, Roberto M., Cuneo, Antonio, Trawinska, Malgorzata M., Vianelli, Nicola, Cavo, Michele, Bonifacio, Massimiliano, Breccia, Massimo

“…Background Anemia is frequently present in patients with myelofibrosis (MF), and it may be exacerbated by treatment with the JAK2‐inhibitor ruxolitinib (RUX)…”
Get full text

Second primary malignancy in myelofibrosis patients treated with ruxolitinib by Polverelli, Nicola, Elli, Elena M., Abruzzese, Elisabetta, Palumbo, Giuseppe A., Benevolo, Giulia, Tiribelli, Mario, Bonifacio, Massimiliano, Tieghi, Alessia, Caocci, Giovanni, D'Adda, Mariella, Bergamaschi, Micaela, Binotto, Gianni, Heidel, Florian H., Cavazzini, Francesco, Crugnola, Monica, Pugliese, Novella, Bosi, Costanza, Isidori, Alessandro, Bartoletti, Daniela, Auteri, Giuseppe, Latagliata, Roberto, Gandolfi, Lisa, Martino, Bruno, Scaffidi, Luigi, Cattaneo, Daniele, D’Amore, Fabio, Trawinska, Malgorzata M., Stella, Rossella, Markovic, Uros, Catani, Lucia, Pane, Fabrizio, Cuneo, Antonio, Krampera, Mauro, Semenzato, Gianpietro, Lemoli, Roberto M., Vianelli, Nicola, Breccia, Massimo, Russo, Domenico, Cavo, Michele, Iurlo, Alessandra, Palandri, Francesca

“…Summary Ruxolitinib (RUX), the first JAK1/JAK2 inhibitor approved for myelofibrosis (MF) therapy, has recently been associated with the occurrence of second…”
Get full text

Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemia by Bocchia, M, Abruzzese, E, Forconi, F, Ippoliti, M, Trawinska, M M, Pirrotta, M T, Raspadori, D, Tozzi, M, Gozzetti, A, Lauria, F

Get full text

Back to the future: Treatment‐free remission and pregnancy in chronic myeloid leukemia by Abruzzese, Elisabetta, de Fabritiis, Paolo, Trawinska, Malgorzata M., Niscola, Pasquale, Apperley, Jane F., Mauro, Michael J.

Get full text

Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic‐phase myelofibrosis by Palandri, Francesca, Bartoletti, Daniela, Iurlo, Alessandra, Bonifacio, Massimiliano, Abruzzese, Elisabetta, Caocci, Giovanni, Elli, Elena M., Auteri, Giuseppe, Tiribelli, Mario, Polverelli, Nicola, Miglino, Maurizio, Heidel, Florian H., Tieghi, Alessia, Benevolo, Giulia, Beggiato, Eloise, Fava, Carmen, Cavazzini, Francesco, Pugliese, Novella, Binotto, Gianni, Bosi, Costanza, Martino, Bruno, Crugnola, Monica, Ottaviani, Emanuela, Micucci, Giorgia, Trawinska, Malgorzata M., Cuneo, Antonio, Bocchia, Monica, Krampera, Mauro, Pane, Fabrizio, Lemoli, Roberto M., Cilloni, Daniela, Vianelli, Nicola, Cavo, Michele, Palumbo, Giuseppe A., Breccia, Massimo

“…Background The presence of peripheral blasts (PB) is a negative prognostic factor in patients with primary and secondary myelofibrosis (MF) and PB ≥4% was…”
Get full text

Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia by Raspadori, Donatella, Pacelli, Paola, Sicuranza, Anna, Abruzzese, Elisabetta, Iurlo, Alessandra, Cattaneo, Daniele, Gozzini, Antonella, Galimberti, Sara, Baratè, Claudia, Pregno, Patrizia, Nicolosi, Maura, Sorà, Federica, Annunziata, Mario, Luciano, Luigiana, Caocci, Giovanni, Moretti, Sabrina, Sgherza, Nicola, Fozza, Claudio, Russo, Sabina, Usala, Emilio, Liberati, Marina A., Ciofini, Sara, Trawinska, Monika M., Gozzetti, Alessandro, Bocchia, Monica

“…Background Recent investigations in chronic myeloid leukemia (CML) have focused on the identification and characterization of leukemic stem cells (LSCs). These…”
Get full text

A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis by Palandri, Francesca, Palumbo, Giuseppe A., Bonifacio, Massimiliano, Elli, Elena M., Tiribelli, Mario, Auteri, Giuseppe, Trawinska, Malgorzata M., Polverelli, Nicola, Benevolo, Giulia, Tieghi, Alessia, Cavalca, Fabrizio, Caocci, Giovanni, Beggiato, Eloise, Binotto, Gianni, Cavazzini, Francesco, Miglino, Maurizio, Bosi, Costanza, Crugnola, Monica, Bocchia, Monica, Martino, Bruno, Pugliese, Novella, Venturi, Marta, Isidori, Alessandro, Cattaneo, Daniele, Krampera, Mauro, Pane, Fabrizio, Cilloni, Daniela, Semenzato, Gianpietro, Lemoli, Roberto M., Cuneo, Antonio, Abruzzese, Elisabetta, Branzanti, Filippo, Vianelli, Nicola, Cavo, Michele, Heidel, Florian, Iurlo, Alessandra, Breccia, Massimo

“…Most patients with myelofibrosis (MF) discontinue ruxolitinib (JAK1/JAK2 inhibitor) in the first 5 years of therapy due to therapy failure. As the therapeutic…”
Get full text

Primitive “Spindle Cell Variant” (Sarcomatoid Variant) Diffuse Large B-Cell Lymphoma of the Uterine Cervix: Description and Outcome of a Rare Case by Fratoni, Stefano, Abruzzese, Elisabetta, Trawinska, Malgorzata M, Niscola, Pasquale, de Fabritiis, Paolo, Santeusanio, Giuseppe

“…A very rare case of primary diffuse large B-cell lymphoma of the uterine cervix characterized by “spindle cell variant” morphology (“sarcomatoid subtype”) is…”
Get full text

Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host Disease by Tendas, A, Boschetto, C, Baraldi, L, Caiazza, E, Cupelli, L, Lentini, R, Trawinska, M, Palombi, M, Ales, M, Morino, L, Giovannini, M, Scaramucci, L, Cartoni, C, Dentamaro, T, Arcese, W, de Fabritiis, P, Niscola, P, Mandelli, F

“…Chronic graft versus host disease (cGVHD) is a frequent complication of allogeneic stem cell transplantation. Extensive musculoskeletal and skin involvement…”
Get full text